![Stephen Hahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Hahn
Directeur/Membre du Conseil chez
ION BEAM APPLICATIONS, SA
Profil
Stephen M Hahn is currently the Chief Executive Officer at Nucleus Radiopharma, Inc. since 2025.
He is also a Director at Ion Beam Applications SA and Faeth Therapeutics, Inc., both positions starting in 2026.
Mr. Hahn completed undergraduate education at William Marsh Rice University and graduate education at Temple University (Pennsylvania).
Postes actifs de Stephen Hahn
| Sociétés | Poste | Début |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Directeur/Membre du Conseil | 16/06/2026 |
| FAETH THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/06/2026 |
Nucleus Radiopharma, Inc.
 Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Directeur Général | 20/08/2025 |
Formation de Stephen Hahn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ion Beam Applications SA
 Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
Choisissez Zonebourse 
